1) Pro-angiogenic signaling (VEGFR2 Akt eNOS) In cell and animal models, BPC-157 increases VEGFR2 expression/internalization and activates downstream Akt-eNOS signaling, supporting endothelial tube formation and blood-flow recovery after ischemia
With benzodiazepines: While animal studies showed BPC-157 prevented tolerance and enhanced efficacy, the human interaction profile is unknown
Its suggested that BPC 157 enhances the recovery and repair of neuronal pathways and reduces overall neuronal damage
TB-500 (T-4) and BPC-157 combines two peptides to promote wound repair at a cellular level through Angiogenesis (growth of new blood vessels), increase collagen formation, and also provides immunomodulating effects that reduces the develop of pro-inflammatory cytokines, development of fibrous (scar) tissue, and boost immune system functions
However, oral bioavailability in humans is poorly quantified, so dosing is even less predictable than with injection